Tackling the risk of hyperkalemia through guideline-recommended heart failure therapy

1-3 of 3

• 

  RestartResume

  Treating hyperkalemia in patients with HF

  RestartResume

  Treating hyperkalemia in patients with HF

  Tackling the risk of hyperkalemia through guideline-recommended heart failure therapy

  Treating hyperkalemia in patients with HF

  Mikhail Kosiborod, MD

  • 

    

    Mikhail Kosiborod, MD

• 

  RestartResume

  Prescribing and monitoring novel potassium binders for optimizing RAASi therapy in HF

  RestartResume

  Prescribing and monitoring novel potassium binders for optimizing RAASi therapy in HF

  Tackling the risk of hyperkalemia through guideline-recommended heart failure therapy

  Prescribing and monitoring novel potassium binders for optimizing RAASi therapy in HF

  Aaron Wong, MD

  • 

    

    Aaron Wong, MD

• 

  RestartResume

  The key role of RAASi therapy in patients with HF

  RestartResume

  The key role of RAASi therapy in patients with HF

  Tackling the risk of hyperkalemia through guideline-recommended heart failure therapy

  The key role of RAASi therapy in patients with HF

  Shelley Zieroth, MD

  • 

    

    Shelley Zieroth, MD